The pharmaceutical procurement landscape is evolving rapidly, moving beyond traditional cost-focused approaches toward sophisticated value-based models that consider multiple factors […]

Navigating the Intersection of IPR and Hatch-Waxman Litigation: Strategic Coordination for Patent ChallengesBalancing inter partes review (IPR) proceedings with Hatch-Waxman

The generic pharmaceutical industry represents a massive opportunity for businesses that can successfully navigate its complex landscape. With the global

The fight against biologic drug patent thickets is undergoing significant transformation through legislative reforms, strategic litigation approaches, and international policy

Executive Summary The pharmaceutical industry faces increasing complexity and costs in research and development (R&D), necessitating innovative approaches to optimize

I. Introduction: Navigating the Landscape of Pharmaceutical Patents with the FDA Orange and Purple Books Patent information holds a position

Computational drug repurposing represents one of the most promising avenues for accelerating drug development in the modern pharmaceutical landscape. By

The management of prescription drug benefits by Pharmacy Benefit Managers (PBMs) represents a complex and often opaque aspect of the

In the complex and highly regulated pharmaceutical industry, procurement mistakes can have devastating financial consequences that ripple throughout an organization.